- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07244354
Maternal Hypothermia After Caesarean Section - Implications for Postoperative Recovery
July 23, 2026 updated by: Elizabeth Reine, Oslo University Hospital
The aim of the study is to assess patient reported outcomes after caesarean section using self report questionnaire.
Study Overview
Status
Enrolling by invitation
Conditions
Intervention / Treatment
Detailed Description
The project consists of two studies: Study 1 explores patient reported outcomes after caesarean section related to recovery and quality of care.
Study 2 explores possible associations between perioperative hypothermia during caesarean section and postoperative infection
Study Type
Observational
Enrollment (Estimated)
700
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Oslo
-
Oslo, Oslo, Norway
- Oslo University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
N/A
Sampling Method
Non-Probability Sample
Study Population
Females giving birth through caesarean section
Description
Inclusion Criteria: Caesarean section surgery -
Exclusion Criteria: Stillborn baby, baby admitted to neonatal intensive care,
-
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient reported recovery after caesarean delivery and symptoms of post caesarean infection
Time Frame: Data collection 24 hours after surgery and 7 days after surgery and 30 days after surgery
|
Data collection using questionnaire
|
Data collection 24 hours after surgery and 7 days after surgery and 30 days after surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Elizabeth Reine, PhD, Oslo University Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2026
Primary Completion (Estimated)
November 1, 2030
Study Completion (Estimated)
November 1, 2030
Study Registration Dates
First Submitted
November 17, 2025
First Submitted That Met QC Criteria
November 17, 2025
First Posted (Actual)
November 24, 2025
Study Record Updates
Last Update Posted (Actual)
July 24, 2026
Last Update Submitted That Met QC Criteria
July 23, 2026
Last Verified
January 1, 2026
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 911621
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.